Status:
COMPLETED
Severe Pandemic H1N1 Infection in ICU: Comparative Resource Utilization
Lead Sponsor:
University of Manitoba
Collaborating Sponsors:
GlaxoSmithKline
Conditions:
Novel H1N1 Influenzal Acute Respiratory Infection
Eligibility:
All Genders
18+ years
Brief Summary
The main purpose of this study is to review the resource utilization of severe adult H1N1 pneumonia undergoing antiviral and oxygen therapy, mechanical ventilation and support with pulmonary rescue th...
Eligibility Criteria
Inclusion
- \> 18years,
- Suspected or confirmed influenza (Appendix A)
- Requirement for ICU admission due to respiratory distress or critical illness defined as one of:a) Inspired oxygen need of \>50% for at least 4 hours (For FiO2 for non-intubated patients see Appendix B) b) mechanical ventilation c) Patient is receiving inotrope or vasopressor
Exclusion
- 1\. Age less than 18 years
Key Trial Info
Start Date :
October 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT01485237
Start Date
October 1 2009
End Date
December 1 2012
Last Update
December 2 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Health Sciences Centre, Winnipeg
Winnipeg, Manitoba, Canada, R3A 1R9